Enopia, Rosiela D.
HRN: 22-77-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2024
CEFUROXIME 1.5GM (VIAL)
02/26/2024
02/27/2024
IV
1.5g
Q8 X 3 Doses
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes